PAVmed Inc. Common Stock

PAVMNASDAQ • USD
2.77 USD
↗ 0.11 (3.95%)🟢LIVE (AS OF 12:44 PM EDT)
🟢Market: OPEN

PAVmed Inc. Common Stock (PAVM) is currently trading at $2.77. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, PAVM trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Oct 5, 2026.

Open?$2.65
High?$2.83
Low?$2.65
Prev. Close?$2.66
Volume?13.1K
Avg. Volume?26.7K
VWAP?$2.71
Rel. Volume?0.49x
Bid / Ask
Bid?$2.24 × 100
Ask?$3.33 × 100
Spread?$1.09
Midpoint?$2.79
Valuation & Ratios
Market Cap?21.3M
Shares Out?8.0M
Float?4.4M
Float %?60.3%
P/E Ratio?N/A
P/B Ratio?0.61
EPS?-$2.58
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.
Employees
41
Market Cap
21.3M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2016-04-28
Address
360 MADISON AVENUE
NEW YORK, NY 10017
Phone: (212) 949-4319
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
0
Momentum?
77
Short Sent.?
60
Piotroski F-Score?4/9Mixed
Altman Z-Score?-10.51Distress
Confidence?48%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.25%Low
Short Interest?10.8K
Days to Cover?1.0
Free Float4.4M
Avg Daily Volume31.5K
Settlement Date2026-09-15
Financial Health
Current Ratio?1.19Adequate
Quick Ratio?1.19Adequate
Cash Ratio?0.93Adequate
Debt/Equity?0.43Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.61CHEAP▾
P/S?
Peers
100
S&P
3
189.90HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.4CHEAP▾
EV/Sales?
Peers
100
S&P
3
290.94HIGH▾
Returns & Efficiency
ROE?
S&P
3
-58.9%WEAK▾
ROA?
S&P
3
-51.3%WEAK▾
Cash Flow & Enterprise
FCF?$-7782000
Enterprise Value?$32.6M
Fundamentals ratios updated end of day